XNYS
AFL
Market cap58bUSD
Oct 08, Last price
114.94USD
1D
1.95%
1Q
-5.72%
Jan 2017
230.29%
Name
Aflac Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
Related entities
Subsidiaries (8)
AFLAC ASSET MANAGEMENT LLC
AMERICAN FAMILY LIFE ASSURANCE COMPANY OF COLUMBUS
CONTINENTAL AMERICAN INSURANCE COMPANY
TIER ONE INSURANCE COMPANY
AFLAC ASSET MANAGEMENT JAPAN LTD.
Aflac Life Insurance Japan Ltd.
Aflac Re Bermuda Ltd.
American Family Life Assurance Company of New York
Key people
Virgil Miller
President, President - Aflac U.S. · since 2025
Masatoshi Koide
President and Representative Director, Aflac Japan · since 2018
Charles Lake
President - Aflac International · since 2014
Steven Beaver
Executive Vice President, Chief Financial Officer, Aflac Japan · since 2024
Chief Financial Officer, Senior Executive Vice President · since 2025
Bradley Dyslin
Executive Vice President, Global Chief Investment Officer · since 2023
Frederic Simard
Executive Vice President - Aflac U.S., Chief Operating Officer, Aflac U.S., Chief Financial Officer, Aflac U.S. · since 2025
Robin Blackmon
Senior Vice President - Financial Services, Chief Accounting Officer · since 2024
Senior Executive Vice President, General Counsel · since 2025
Lead Independent Director · since 2019
Daniel Amos
Chairman of the Board, Chief Executive Officer · since 2025
Independent Director · since 2022
Miwako Hosoda
Independent Director · since 2023
Thomas Kenny
Independent Director · since 2015
Independent Director · since 2019
Karole Lloyd
Independent Director · since 2017
Nobuchika Mori
Independent Director · since 2020
Joseph Moskowitz
Independent Director · since 2015
Katherine Rohrer
Independent Director · since 2017
Legal address
C/O AUDREY BOONE TILLMAN
1932 WYNNTON ROAD
COLUMBUS, GA 31999
US
1932 WYNNTON ROAD
COLUMBUS, GA 31999
US
Headquarters
1932 WYNNTON ROAD
COLUMBUS, GA 31999
US
COLUMBUS, GA 31999
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||